全文获取类型
收费全文 | 86305篇 |
免费 | 8858篇 |
国内免费 | 6433篇 |
专业分类
耳鼻咽喉 | 655篇 |
儿科学 | 1120篇 |
妇产科学 | 902篇 |
基础医学 | 9392篇 |
口腔科学 | 1623篇 |
临床医学 | 12097篇 |
内科学 | 12262篇 |
皮肤病学 | 945篇 |
神经病学 | 4035篇 |
特种医学 | 3228篇 |
外国民族医学 | 32篇 |
外科学 | 7555篇 |
综合类 | 16094篇 |
现状与发展 | 25篇 |
一般理论 | 8篇 |
预防医学 | 6570篇 |
眼科学 | 2512篇 |
药学 | 9593篇 |
135篇 | |
中国医学 | 5655篇 |
肿瘤学 | 7158篇 |
出版年
2024年 | 362篇 |
2023年 | 1600篇 |
2022年 | 4002篇 |
2021年 | 4960篇 |
2020年 | 3976篇 |
2019年 | 2967篇 |
2018年 | 3132篇 |
2017年 | 2913篇 |
2016年 | 2709篇 |
2015年 | 4175篇 |
2014年 | 5014篇 |
2013年 | 4681篇 |
2012年 | 6753篇 |
2011年 | 7278篇 |
2010年 | 4784篇 |
2009年 | 3801篇 |
2008年 | 4600篇 |
2007年 | 4610篇 |
2006年 | 4407篇 |
2005年 | 4309篇 |
2004年 | 2598篇 |
2003年 | 2329篇 |
2002年 | 1882篇 |
2001年 | 1762篇 |
2000年 | 1782篇 |
1999年 | 1874篇 |
1998年 | 1174篇 |
1997年 | 1200篇 |
1996年 | 901篇 |
1995年 | 869篇 |
1994年 | 741篇 |
1993年 | 438篇 |
1992年 | 530篇 |
1991年 | 482篇 |
1990年 | 417篇 |
1989年 | 359篇 |
1988年 | 312篇 |
1987年 | 288篇 |
1986年 | 223篇 |
1985年 | 155篇 |
1984年 | 81篇 |
1983年 | 59篇 |
1982年 | 37篇 |
1981年 | 22篇 |
1980年 | 21篇 |
1979年 | 25篇 |
1978年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 14 毫秒
41.
该文总结该市2017年1月-2018年12月之间,在无偿献血宣传招募方面工作内容。结果显示2018年较2017年献血总量有所提升,其中团体献血所占比例逐渐上升,街头献血所占比例逐渐下降。通过大力宣传无偿献血工作,扩大无偿献血团体招募工作,完善并深化无偿献血各项制度,使得普通群众的无偿献血认知度不断提高。 相似文献
42.
Membrane trafficking processes are presumably vital for axonal regeneration after injury, but mechanistic understanding in this regard has been sparse. A recent loss-of-function screen had been carried out for factors important for axonal regeneration by cultured cortical neurons and the results suggested that the activity of a number of Rab GTPases might act to restrict axonal regeneration. A loss of Rab27b, in particular, is shown to enhance axonal regeneration in vitro, as well as in C. elegans and mouse central nervous system injury models in vivo. Possible mechanisms underlying this new finding, which has important academic and translational implication, are discussed. 相似文献
43.
45.
Qian S Zhang Brian L Browning Sharon R Browning 《European journal of human genetics : EJHG》2015,23(5):672-677
We performed genome-wide tests for association between haplotype clusters and each of 9 metabolic traits in a cohort of 5402 Northern Finnish individuals genotyped for 330 000 single-nucleotide polymorphisms. The metabolic traits were body mass index, C-reactive protein, diastolic blood pressure, glucose, high-density lipoprotein (HDL), insulin, low-density lipoprotein (LDL), systolic blood pressure, and triglycerides. Haplotype clusters were determined using Beagle. There were LDL-associated clusters in the chromosome 4q13.3-q21.1 region containing the albumin (ALB) and platelet factor 4 (PF4) genes. This region has not been associated with LDL in previous genome-wide association studies. The most significant haplotype cluster in this region was associated with 0.488 mmol/l higher LDL (95% CI: 0.361–0.615 mmol/l, P-value: 6.4 × 10−14). We also observed three previously reported associations: Chromosome 16q13 with HDL, chromosome 1p32.3-p32.2 with LDL and chromosome 19q13.31-q13.32 with LDL. The chromosome 1 and chromosome 4 LDL associations do not reach genome-wide significance in single-marker analyses of these data, illustrating the power of haplotypic association testing. 相似文献
46.
目的探讨化浊解毒方治疗溃疡性结肠炎(UC)的治疗作用及机制。方法120例UC患者按照随机数字表法分为观察组、对照组各60例。观察组予中药化浊解毒方口服,每日1剂,早晚2次温服;对照组予美沙拉嗪肠溶片口服,1.0 g/次,3次/d。2组疗程均4周。对比2组治疗前后Geboes指数、结肠镜下黏膜表现、生活质量评分、疾病活动指数及血清炎性因子IL-8、IL-35水平,凝血指标血清FIB水平,统计治疗后1年内复发情况。结果治疗后,观察组Geboes指数、疾病活动指数及血清炎性因子IL-8水平、凝血指标血清FIB水平均较本组治疗前降低,生活质量评分、血清炎性因子IL-35水平升高(P<0.05);且观察组治疗后疾病活动指数及血清炎性因子IL-8水平、凝血指标血清FIB水平均低于对照组,生活质量评分、血清炎性因子IL-35水平均高于对照组(P<0.05)。与对照组相比,治疗组糜烂、溃疡改善不明显(P>0.05),充血水肿、颗粒样变等肠镜表现改善情况均优于对照组(P<0.05)。治疗结束1年观察组复发率为10.64%,对照组为23.53%,2组差异有统计学意义(P<0.05)。结论化浊解毒方能改善UC患者临床症状,修复肠黏膜病理损伤,降低复发率;其机制可能与调节血清炎性因子IL-8、IL-35和凝血因子FIB水平有关。 相似文献
47.
48.
Ye Gao Lei Xin Yu-Xin Wang Yuan-Hang Dong Zhuan Liao 《Scandinavian journal of gastroenterology》2020,55(1):105-113
AbstractBackground and aim: Capsule retention is the most common adverse event associated with video capsule endoscopy. The use of double-balloon enteroscopy-assisted capsule endoscope retrieval has been increasingly reported in recent years. However, evidence is limited regarding its success rate, associated factors, and subsequent clinical outcomes.Methods: A systematic review of relevant studies published before January 2019 was performed. Successful retrieval rate and associated factors, rate of endoscopic balloon dilation, and outcomes after double-balloon enteroscopy were summarized and pooled.Results: Within 154 associated original articles, 12 including 150 cases of capsule retrieval by double-balloon enteroscopy were included. The estimated pooled successful retrieval rate was 86.5% (95% confidence interval, 75.6–95.1%). Anterograde approach and capsules retained in the jejunum or trapped by malignant strictures were associated with a higher successful retrieval rate than the retrograde approach (62/83 [74.7%] vs. 10/38 [26.3%], p?<?.001) and capsules retained in the ileum (41/41 [100.0%] vs. 43/58 [74.1%], p?<?.001) or trapped by benign strictures (21/21 [100.0%] vs. 65/83 [78.3%], p?=?.043). Endoscopic balloon dilation was performed in 38.8% (95% confidence interval, 22.3–56.3%) of patients with benign strictures. Two perforations (1.3%) were reported as severe adverse events after double-balloon enteroscopy. A significantly lower surgery rate was found among cases with successful video capsule removal compared with unsuccessful cases (7.2% vs. 38.5%, p?=?.002).Conclusions: Double-balloon enteroscopy is feasible and safe for removing retained video capsule endoscopes, and its use could decrease the need for surgery in patients with benign strictures and facilitate subsequent surgery in patients with malignant strictures. 相似文献
49.
Joseph Biederman Haitao Gao Ann K Rogers Thomas J Spencer 《Neuropsychopharmacology》2006,60(10):1106-1110
BACKGROUND: The validity of parent reports regarding children's attention-deficit/hyperactivity disorder (ADHD) symptoms has been questioned. This study assessed whether parent reports were as sensitive as teacher reports to document change in ADHD symptoms during clinical trials with atomoxetine. METHODS: Data were compared from two randomized, double-blind, placebo-controlled clinical trials of atomoxetine using different versions (parent or teacher) of the same rating scale (Attention-Deficit/Hyperactivity Disorder Rating Scale-IV [parent or teacher] Version: Investigator Administered and Scored - ADHD RS). Exclusion criteria included history of bipolar disorder, psychosis, seizures, alcohol abuse, or positive drug screen. Patients (6-16 years old) were treated with atomoxetine (titrated to a maximum dose of 1.8 mg/kg/day) administered once daily for up to 7 weeks. Parent and teacher ratings were compared using an analysis of covariance (ANCOVA) model. RESULTS: The analysis (n = 318) showed that treatment effects (mean change, baseline to endpoint) were similar between parent and teacher ratings (total, p = .762; inattention, p = .519; hyperactive/impulsive, p = .955). Effect sizes also were similar based on total scores (parent ratings = .69; teacher ratings = .63). CONCLUSIONS: Parent reports are as sensitive as teacher reports in assessing the efficacy of long-acting pharmacologic treatment for ADHD in children during clinical trials using the nonstimulant atomoxetine. 相似文献
50.